share_log

Biodexa Pharmaceuticals | EFFECT: Others

SEC announcement ·  May 3 06:06
Summary by Moomoo AI
The United States Securities and Exchange Commission (SEC) has declared that Biodexa Pharmaceuticals Plc's submission has become effective as of May 2, 2024. The submission, identified by Accession Number 0001214659-24-007806 and File Number 333-240984, was a post-effective amendment (POS AM) to a previously filed registration statement. This notice of effectiveness indicates that the SEC has reviewed and accepted the company's submission, allowing Biodexa Pharmaceuticals to proceed with the actions outlined in the amendment.
The United States Securities and Exchange Commission (SEC) has declared that Biodexa Pharmaceuticals Plc's submission has become effective as of May 2, 2024. The submission, identified by Accession Number 0001214659-24-007806 and File Number 333-240984, was a post-effective amendment (POS AM) to a previously filed registration statement. This notice of effectiveness indicates that the SEC has reviewed and accepted the company's submission, allowing Biodexa Pharmaceuticals to proceed with the actions outlined in the amendment.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more